Lifestyle Delivery Systems Inc.
Lifestyle Delivery Systems Inc. Announces Revenue Generated by its Affiliate, CSPA GROUP, Inc.
DGAP-News: Lifestyle Delivery Systems Inc. / Key word(s): Development of Sales/Interim Report Lifestyle Delivery Systems Inc. Announces Revenue Generated by its Affiliate, CSPA GROUP, Inc. The revenue was associated with sales of extracted distillate in the last week of June 2018 marking the beginning of white label distillate production. The Company has redesigned all of its packaging for Rêveur and CannaStripsTM to meet the latest California regulations which went into effect on July 1, 2018. The new packaging for Rêveur arrived on July 10, 2018, and CSPA estimates that repackaging of the inventory will be completed by July 18, 2018. The new CannaStripsTM packaging is scheduled to arrive during the last week of July 2018 at which time the production of CannaStripsTM with their new flavours and advanced formulae will begin. The Company will have updates as information becomes available. Extension of Financial Milestones for Escrow Agreements About Lifestyle Delivery Systems Inc. On behalf of the board of directors of Lifestyle Delivery Systems Inc. Brad Eckenweiler Suite 820, 1130 W. Pender St. CSE : LDS OTCQB : LDSYF Frankfurt: LD6, WKN: A14XHT www.lifestyledeliverysystem.com FOR MORE INFORMATION, PLEASE CONTACT: Cautionary Disclaimer Statement: Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.
17.07.2018 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |